WNT2B
Basic information
Region (hg38): 1:112466541-112530165
Previous symbols: [ "WNT13" ]
Links
Phenotypes
GenCC
Source:
- diarrhea 9 (Strong), mode of inheritance: AR
- diarrhea 9 (Limited), mode of inheritance: AR
- diarrhea 9 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Diarrhea 9 | AR | Gastrointestinal | The condition can involve severe and early-onset diarrhea, and awareness may help with management (eg, via parenteral nutrition, which has been described as necessary) | Gastrointestinal | 29909964 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the WNT2B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 48 | 52 | ||||
missense | 60 | 63 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 5 | 5 | ||||
non coding | 9 | |||||
Total | 2 | 0 | 63 | 57 | 7 |
Variants in WNT2B
This is a list of pathogenic ClinVar variants found in the WNT2B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-112509271-A-G | Likely benign (Nov 18, 2023) | |||
1-112509273-C-T | Uncertain significance (Apr 01, 2022) | |||
1-112509274-G-A | Likely benign (Jan 14, 2023) | |||
1-112509274-G-C | Likely benign (Nov 29, 2022) | |||
1-112509275-G-C | not specified | Uncertain significance (Aug 14, 2023) | ||
1-112509285-A-C | Uncertain significance (Jul 01, 2022) | |||
1-112509287-G-A | Benign (Feb 01, 2024) | |||
1-112509297-A-G | Uncertain significance (Aug 06, 2022) | |||
1-112509299-C-T | not specified | Uncertain significance (May 26, 2024) | ||
1-112509309-G-C | Uncertain significance (Jun 22, 2022) | |||
1-112509311-C-T | Uncertain significance (Oct 05, 2022) | |||
1-112509314-G-A | not specified | Uncertain significance (Jul 11, 2023) | ||
1-112509316-C-G | Likely benign (Nov 30, 2022) | |||
1-112509324-C-G | Uncertain significance (Jun 26, 2022) | |||
1-112509327-T-C | not specified | Uncertain significance (Aug 29, 2022) | ||
1-112509329-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
1-112509331-T-C | Likely benign (Feb 22, 2023) | |||
1-112509335-C-A | Uncertain significance (Mar 22, 2022) | |||
1-112509340-G-A | Likely benign (Apr 06, 2022) | |||
1-112509341-C-T | not specified | Uncertain significance (May 05, 2023) | ||
1-112509344-G-A | Likely benign (Jan 30, 2024) | |||
1-112509352-C-T | Likely benign (Jul 27, 2023) | |||
1-112509356-G-C | not specified | Uncertain significance (Dec 28, 2023) | ||
1-112509364-G-A | Likely benign (Oct 04, 2023) | |||
1-112509388-C-G | Likely benign (Sep 10, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
WNT2B | protein_coding | protein_coding | ENST00000369684 | 5 | 63625 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0383 | 0.960 | 125735 | 0 | 13 | 125748 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.51 | 198 | 267 | 0.741 | 0.0000185 | 2492 |
Missense in Polyphen | 60 | 115.19 | 0.52087 | 1074 | ||
Synonymous | -0.0268 | 98 | 97.7 | 1.00 | 0.00000529 | 836 |
Loss of Function | 2.82 | 6 | 19.4 | 0.309 | 0.00000154 | 170 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.000210 | 0.000198 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000529 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Ligand for members of the frizzled family of seven transmembrane receptors. Functions in the canonical Wnt/beta- catenin signaling pathway. Plays a redundant role in embryonic lung development. {ECO:0000250|UniProtKB:O70283}.;
- Pathway
- Gastric cancer - Homo sapiens (human);mTOR signaling pathway - Homo sapiens (human);Cushing,s syndrome - Homo sapiens (human);Breast cancer - Homo sapiens (human);HTLV-I infection - Homo sapiens (human);Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human);Basal cell carcinoma - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Hippo signaling pathway - Homo sapiens (human);Proteoglycans in cancer - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Wnt signaling pathway - Homo sapiens (human);Melanogenesis - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Differentiation Pathway;ESC Pluripotency Pathways;Wnt Signaling Pathway and Pluripotency;Wnt Signaling in Kidney Disease;EMT transition in Colorectal Cancer;Wnt Signaling Pathway;DNA Damage Response (only ATM dependent);Signaling by GPCR;Signaling by WNT;Signal Transduction;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;Class B/2 (Secretin family receptors);GPCR ligand binding;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;WNT ligand biogenesis and trafficking;GPCR signaling-G alpha i;Wnt Canonical;Wnt Mammals
(Consensus)
Recessive Scores
- pRec
- 0.223
Intolerance Scores
- loftool
- 0.851
- rvis_EVS
- -0.54
- rvis_percentile_EVS
- 20.54
Haploinsufficiency Scores
- pHI
- 0.0424
- hipred
- Y
- hipred_score
- 0.735
- ghis
- 0.550
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.379
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Wnt2b
- Phenotype
- respiratory system phenotype; normal phenotype;
Zebrafish Information Network
- Gene name
- wnt2bb
- Affected structure
- extrahepatic duct
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- chondrocyte differentiation;lens development in camera-type eye;male gonad development;cellular response to starvation;Wnt signaling pathway;forebrain regionalization;neuron differentiation;cell fate commitment;canonical Wnt signaling pathway;lung induction;mesenchymal-epithelial cell signaling;iris morphogenesis;cornea development in camera-type eye;hematopoietic stem cell proliferation;positive regulation of branching involved in ureteric bud morphogenesis
- Cellular component
- extracellular region;extracellular space;intracellular membrane-bounded organelle
- Molecular function
- frizzled binding